Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 19, Issue SUPPL. 2, 2008, Pages

  Glimelius, B ^a,c   Oliveira, J ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^c ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ARTICLE; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER THERAPY; CONTINUOUS INFUSION; ENDOSCOPIC SURGERY; EUROPEAN UNION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; METASTASIS; MICRODISSECTION; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RECTOSCOPY; RECTUM BIOPSY; RECTUM CANCER; RECTUM SURGERY; RISK ASSESSMENT; SALVAGE THERAPY; SIGMOIDOSCOPY; INCIDENCE; PATHOLOGY; RECTUM TUMOR; TUMOR RECURRENCE;

FOLLOW-UP STUDIES; HUMANS; INCIDENCE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECTAL NEOPLASMS;

EID: 45149100484     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn078     Document Type: Article

References (11)

1. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-460.
2. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al. Preoperative radiotherapy in combination with total mesorectal excision improves local control in resectable rectal cancer. Report from a multicenter randomized trial. For the Dutch Colo Rectal Cancer Group and other cooperative investigators. New Engl J Med 2001; 345: 638-646.
3. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomised trials. Lancet 2001; 358: 1291-1304.
4. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Review 2002; 1: CD002200.
5. Beets-Tan R, Beets G, Vliegen R et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504.
6. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
7. Folkesson J, Birgisson H, Påhlman L et al. Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23: 5644-5650.
8. Bipat S, Glas AS, Slors FJ et al. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 2004; 232: 773-783.
9. Sebag-Montefiore D for the NCRI colorectal cancer study group and CR0 et al. Routine short course pre-op radiotherapy or selective post-op chemotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomized trial. ASCO Annual Meeting Proceedings Part 1 2006 (18 Suppl): 24 (Abstr 3511).
10. Smalley SR, Benedetti JK, Williamson SK et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006; 24: 3542-3547.
11. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al. Long-term results of a randomised trial comparing preoperative short-course radiotherapy vs preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-1223.